212 related articles for article (PubMed ID: 29038294)
21. Expression and localization of cytosolic sulfotransferase (SULT) 1A1 and SULT1A3 in normal human brain.
Salman ED; Kadlubar SA; Falany CN
Drug Metab Dispos; 2009 Apr; 37(4):706-9. PubMed ID: 19171676
[TBL] [Abstract][Full Text] [Related]
22. Dimerization is responsible for the structural stability of human sulfotransferase 1A1.
Lu LY; Chiang HP; Chen WT; Yang YS
Drug Metab Dispos; 2009 May; 37(5):1083-8. PubMed ID: 19237513
[TBL] [Abstract][Full Text] [Related]
23. Structural plasticity in the human cytosolic sulfotransferase dimer and its role in substrate selectivity and catalysis.
Tibbs ZE; Rohn-Glowacki KJ; Crittenden F; Guidry AL; Falany CN
Drug Metab Pharmacokinet; 2015 Feb; 30(1):3-20. PubMed ID: 25760527
[TBL] [Abstract][Full Text] [Related]
24. Manganese-mefenamic acid complexes exhibit high lipoxygenase inhibitory activity.
Feng J; Du X; Liu H; Sui X; Zhang C; Tang Y; Zhang J
Dalton Trans; 2014 Jul; 43(28):10930-9. PubMed ID: 24903101
[TBL] [Abstract][Full Text] [Related]
25. The gate that governs sulfotransferase selectivity.
Cook I; Wang T; Almo SC; Kim J; Falany CN; Leyh TS
Biochemistry; 2013 Jan; 52(2):415-24. PubMed ID: 23256751
[TBL] [Abstract][Full Text] [Related]
26. Paradigms of sulfotransferase catalysis: the mechanism of SULT2A1.
Wang T; Cook I; Falany CN; Leyh TS
J Biol Chem; 2014 Sep; 289(38):26474-26480. PubMed ID: 25056952
[TBL] [Abstract][Full Text] [Related]
27. Sulfation of apomorphine by human sulfotransferases: evidence of a major role for the polymorphic phenol sulfotransferase, SULT1A1.
Thomas NL; Coughtrie MW
Xenobiotica; 2003 Nov; 33(11):1139-48. PubMed ID: 14660177
[TBL] [Abstract][Full Text] [Related]
28. In vitro inhibition of thyroid hormone sulfation by polychlorobiphenylols: isozyme specificity and inhibition kinetics.
Schuur AG; van Leeuwen-Bol I; Jong WM; Bergman A; Coughtrie MW; Brouwer A; Visser TJ
Toxicol Sci; 1998 Oct; 45(2):188-94. PubMed ID: 9848125
[TBL] [Abstract][Full Text] [Related]
29. Sulphation of o-desmethylnaproxen and related compounds by human cytosolic sulfotransferases.
Falany CN; Ström P; Swedmark S
Br J Clin Pharmacol; 2005 Dec; 60(6):632-40. PubMed ID: 16305588
[TBL] [Abstract][Full Text] [Related]
30. Natural products isolated from Mexican medicinal plants: novel inhibitors of sulfotransferases, SULT1A1 and SULT2A1.
Mesía-Vela S; Sańchez RI; Estrada-Muñiz E; Alavez-Solano D; Torres-Sosa C; Jiménez M; Estrada ; Reyes-Chilpa R; Kauffman FC
Phytomedicine; 2001 Nov; 8(6):481-8. PubMed ID: 11824526
[TBL] [Abstract][Full Text] [Related]
31. The potent inhibition of human cytosolic sulfotransferase 1A1 by 17α-ethinylestradiol is due to interactions with isoleucine 89 on loop 1.
Rohn-Glowacki KJ; Falany CN
Horm Mol Biol Clin Investig; 2014 Dec; 20(3):81-90. PubMed ID: 25418972
[TBL] [Abstract][Full Text] [Related]
32. Curcumin is a potent inhibitor of phenol sulfotransferase (SULT1A1) in human liver and extrahepatic tissues.
Vietri M; Pietrabissa A; Mosca F; Spisni R; Pacifici GM
Xenobiotica; 2003 Apr; 33(4):357-63. PubMed ID: 12745871
[TBL] [Abstract][Full Text] [Related]
33. Sulfation of 12-hydroxy-nevirapine by human SULTs and the effects of genetic polymorphisms of SULT1A1 and SULT2A1.
Kurogi K; Cao Y; Segawa K; Sakakibara Y; Suiko M; Uetrecht J; Liu MC
Biochem Pharmacol; 2022 Oct; 204():115243. PubMed ID: 36084709
[TBL] [Abstract][Full Text] [Related]
34. Sulfation of resveratrol in human liver: evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1.
Miksits M; Maier-Salamon A; Aust S; Thalhammer T; Reznicek G; Kunert O; Haslinger E; Szekeres T; Jaeger W
Xenobiotica; 2005 Dec; 35(12):1101-19. PubMed ID: 16418064
[TBL] [Abstract][Full Text] [Related]
35. Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3.
Barnett AC; Tsvetanov S; Gamage N; Martin JL; Duggleby RG; McManus ME
J Biol Chem; 2004 Apr; 279(18):18799-805. PubMed ID: 14871892
[TBL] [Abstract][Full Text] [Related]
36. Crystal structures of human sulfotransferases: insights into the mechanisms of action and substrate selectivity.
Dong D; Ako R; Wu B
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):635-46. PubMed ID: 22512672
[TBL] [Abstract][Full Text] [Related]
37. Polychlorobiphenylols are selective inhibitors of human phenol sulfotransferase 1A1 with 4-nitrophenol as a substrate.
Wang LQ; Lehmler HJ; Robertson LW; James MO
Chem Biol Interact; 2006 Feb; 159(3):235-46. PubMed ID: 16413005
[TBL] [Abstract][Full Text] [Related]
38. Structure, function and polymorphism of human cytosolic sulfotransferases.
Lindsay J; Wang LL; Li Y; Zhou SF
Curr Drug Metab; 2008 Feb; 9(2):99-105. PubMed ID: 18288952
[TBL] [Abstract][Full Text] [Related]
39. Interactions of cytosolic sulfotransferases with xenobiotics.
James MO; Ambadapadi S
Drug Metab Rev; 2013 Nov; 45(4):401-14. PubMed ID: 24188364
[TBL] [Abstract][Full Text] [Related]
40. Structure of a human carcinogen-converting enzyme, SULT1A1. Structural and kinetic implications of substrate inhibition.
Gamage NU; Duggleby RG; Barnett AC; Tresillian M; Latham CF; Liyou NE; McManus ME; Martin JL
J Biol Chem; 2003 Feb; 278(9):7655-62. PubMed ID: 12471039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
